Section 21: Ophthalmological Preparations

21.1 ANTI-INFECTIVE AGENTS

¤gentamicin solution (eye drops), 0.3%

(as sulfate)

¤idoxuridine solution (eye drops), 0.1%

eye ointment, 0.2%

silver nitrate solution (eye drops), 1%

¤tetracycline eye ointment, 1% (hydrochloride)

21.2 ANTI-INFLAMMATORY AGENTS

¤prednisolone solution (eye drops), 0.5%

(sodium phosphate)

21.3 LOCAL ANAESTHETICS

¤tetracaine solution (eye drops), 0.5%

(hydrochloride)

21.4 MIOTICS AND ANTIGLAUCOMA DRUGS

acetazolamide tablet, 250 mg

¤ Example of a therapeutic group. Various drugs can serve as alternatives.

4 All plasma fractions should comply with the Requirements for the Collection, Processing and Quality Control of Blood,

Blood components and Plasma Derivatives (Revised 1992). WHO Technical Report Series, No. 840, 1994, Annex 2.

5 All vaccines should comply with the WHO requirements for biological substances.

Essential Drugs

¤pilocarpine solution (eye drops), 2%, 4%

(hydrochloride or nitrate)

¤timolol solution (eye drops), 0.25%, 0.5%

(as maleate)

21.5 MYDRIATICS

atropine solution (eye drops),

0.1%, 0.5%, 1% (sulfate)

Complementary drug

epinephrine (A) solution (eye drops), 2%

(as hydrochloride)